Healthcare provider profile · identity verified

Mark L Martinez, MD

Internal Medicine · SALT LAKE CITY, UT · NPI 1508861964

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	343	67
Eliquis	Apixaban	292	43
Gabapentin	Gabapentin	259	64
Trazodone Hcl	Trazodone Hcl	257	42
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	240	38
Levetiracetam	Levetiracetam	238	34
Levothyroxine Sodium	Levothyroxine Sodium	225	45
Potassium Chloride	Potassium Chloride	214	37
Sertraline Hcl	Sertraline Hcl	167	30
Amlodipine Besylate	Amlodipine Besylate	166	33
Baclofen	Baclofen	159	28
Escitalopram Oxalate	Escitalopram Oxalate	159	25
Furosemide	Furosemide	140	34
Lisinopril	Lisinopril	133	25
Budesonide	Budesonide	118	14
Buspirone Hcl	Buspirone Hcl	118	22
Duloxetine Hcl	Duloxetine Hcl	109	19
Acetic Acid	Acetic Acid	106	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	97	18
Mupirocin	Mupirocin	88	18
Ondansetron Hcl	Ondansetron Hcl	79	38
Fluticasone Propionate	Fluticasone Propionate	73	14
Metoprolol Tartrate	Metoprolol Tartrate	73	24
Carvedilol	Carvedilol	69	17
Meropenem	Meropenem	68	suppressed
Albuterol Sulfate	Albuterol Sulfate	67	26
Metoclopramide Hcl	Metoclopramide Hcl	67	12
Xarelto	Rivaroxaban	65	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	61	13
Ondansetron Odt	Ondansetron	59	24
Alendronate Sodium	Alendronate Sodium	58	suppressed
Montelukast Sodium	Montelukast Sodium	58	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	57	suppressed
Hydrocortisone	Hydrocortisone	56	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	55	suppressed
Oxycodone Hcl	Oxycodone Hcl	54	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	51	17
Metformin Hcl	Metformin Hcl	51	11
Myrbetriq	Mirabegron	50	suppressed
Allopurinol	Allopurinol	49	suppressed
Metoprolol Succinate	Metoprolol Succinate	49	15
Pregabalin	Pregabalin	49	13
Quetiapine Fumarate	Quetiapine Fumarate	49	11
Tizanidine Hcl	Tizanidine Hcl	49	suppressed
Lamotrigine	Lamotrigine	48	suppressed
Levofloxacin	Levofloxacin	48	23
Scopolamine	Scopolamine	48	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	47	13
Aripiprazole	Aripiprazole	45	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	43	20
Clopidogrel	Clopidogrel Bisulfate	42	suppressed
Nystatin	Nystatin	42	12
Oxybutynin Chloride Er	Oxybutynin Chloride	42	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	41	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	41	suppressed
Warfarin Sodium	Warfarin Sodium	41	suppressed
Amiodarone Hcl	Amiodarone Hcl	40	suppressed
Donepezil Hcl	Donepezil Hcl	40	suppressed
Clonazepam	Clonazepam	39	suppressed
Enulose	Lactulose	39	suppressed
Glycopyrrolate	Glycopyrrolate	39	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	39	22
Topiramate	Topiramate	39	suppressed
Tramadol Hcl	Tramadol Hcl	39	15
Bupropion Xl	Bupropion Hcl	38	suppressed
Ipratropium Bromide	Ipratropium Bromide	37	suppressed
Midodrine Hcl	Midodrine Hcl	37	13
Ropinirole Hcl	Ropinirole Hcl	37	suppressed
Famotidine	Famotidine	36	14
Finasteride	Finasteride	36	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	36	16
Spironolactone	Spironolactone	36	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	35	17
Diclofenac Sodium	Diclofenac Sodium	35	15
Mirtazapine	Mirtazapine	35	12
Sevelamer Carbonate	Sevelamer Carbonate	35	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	34	suppressed
Omeprazole	Omeprazole	34	17
Risperidone	Risperidone	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	13
Celecoxib	Celecoxib	30	suppressed
Methenamine Hippurate	Methenamine Hippurate	30	suppressed
Olanzapine	Olanzapine	30	suppressed
Cephalexin	Cephalexin	29	17
Lacosamide	Lacosamide	29	suppressed
Movantik	Naloxegol Oxalate	29	suppressed
Zonisamide	Zonisamide	27	suppressed
Farxiga	Dapagliflozin Propanediol	26	suppressed
Losartan Potassium	Losartan Potassium	26	suppressed
Alprazolam	Alprazolam	25	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	25	suppressed
Lorazepam	Lorazepam	25	15
Atrovent Hfa	Ipratropium Bromide	24	suppressed
Bumetanide	Bumetanide	24	suppressed
Jardiance	Empagliflozin	24	suppressed
Meropenem-0.9% Nacl	Meropenem-0.9% Sodium Chloride	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Fanapt	Iloperidone	23	suppressed
Incruse Ellipta	Umeclidinium Bromide	23	suppressed
Sodium Chloride	0.9 % Sodium Chloride	23	15
Digoxin	Digoxin	22	suppressed
Linzess	Linaclotide	22	suppressed
Vancomycin Hcl	Vancomycin/Water For Inj (Peg)	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Entresto	Sacubitril/Valsartan	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Levalbuterol Hcl	Levalbuterol Hcl	20	suppressed
Phenytoin	Phenytoin	20	suppressed
Glipizide	Glipizide	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Prednisone	Prednisone	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	13
Dulera	Mometasone/Formoterol	18	suppressed
Fluconazole	Fluconazole	18	12
Insulin Lispro	Insulin Lispro	17	suppressed
Metolazone	Metolazone	17	suppressed
Modafinil	Modafinil	17	suppressed
Oxcarbazepine	Oxcarbazepine	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	15
Rosuvastatin Calcium	Rosuvastatin Calcium	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Piperacillin-Tazobactam	Piperacillin Sodium/Tazobactam	16	suppressed
Prazosin Hcl	Prazosin Hcl	16	suppressed
Sodium Bicarbonate	Sodium Bicarbonate	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Lidocaine Hcl	Lidocaine Hcl	15	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Ceftriaxone	Ceftriaxone Sodium	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	14	suppressed
Ursodiol	Ursodiol	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Benazepril Hcl	Benazepril Hcl	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Torsemide	Torsemide	13	suppressed
Acetazolamide Er	Acetazolamide	12	suppressed
Aptiom	Eslicarbazepine Acetate	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Norditropin Flexpro	Somatropin	12	suppressed
Valsartan	Valsartan	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Naltrexone Hcl	Naltrexone Hcl	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error